Adaptimmune Therapeutics plc (ADAP)

NASDAQ: ADAP · IEX Real-Time Price · USD

1.170

-0.010 (-0.85%)

At close: Jul 19, 2024, 4:00 PM

1.080

-0.090 (-7.69%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Adaptimmune Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Revenue	18.36	60.28	27.15	6.15	3.96	1.12	Upgrade
Revenue Growth (YoY)	-74.21%	122.05%	341.50%	55.36%	252.76%	-98.11%	Upgrade
Gross Profit	18.36	60.28	27.15	6.15	3.96	1.12	Upgrade
Selling, General & Admin	72.85	73.51	63.39	57.31	45.8	43.39	Upgrade
Research & Development	136.17	126.51	127.73	111.09	91.57	97.5	Upgrade
Operating Expenses	209.02	200.02	191.11	168.4	137.36	140.89	Upgrade
Operating Income	-190.66	-139.74	-163.97	-162.25	-133.41	-139.77	Upgrade
Other Expense / Income	-28.49	-27.21	-1.01	-4.95	-3.48	-2.85	Upgrade
Pretax Income	-162.17	-112.54	-162.96	-157.3	-129.93	-136.92	Upgrade
Income Tax	1.24	1.34	2.5	0.79	0.16	0.24	Upgrade
Net Income	-163.41	-113.87	-165.46	-158.09	-130.09	-137.17	Upgrade
Shares Outstanding (Basic)	1,451	1,206	967	935	855	630	Upgrade
Shares Outstanding (Diluted)	1,451	1,206	967	935	855	630	Upgrade
Shares Change	45.08%	24.73%	3.47%	9.36%	35.72%	7.78%	Upgrade
EPS (Basic)	-0.66	-0.54	-1.02	-1.02	-0.90	-1.32	Upgrade
EPS (Diluted)	-0.66	-0.54	-1.02	-1.02	-0.90	-1.32	Upgrade
Free Cash Flow	-137.98	-145.56	-171.27	2.16	-55.93	-114.1	Upgrade
Free Cash Flow Per Share	-0.57	-0.72	-1.06	0.01	-0.39	-1.09	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-1038.56%	-231.82%	-603.97%	-2638.58%	-3370.52%	-12457.22%	Upgrade
Profit Margin	-890.13%	-188.90%	-609.46%	-2570.99%	-3286.81%	-12225.04%	Upgrade
Free Cash Flow Margin	-751.61%	-241.47%	-630.86%	35.05%	-1413.14%	-10169.25%	Upgrade
EBITDA	-151.35	-102.7	-156.88	-150.73	-122.34	-128.91	Upgrade
EBITDA Margin	-824.43%	-170.36%	-577.88%	-2451.33%	-3090.85%	-11489.57%	Upgrade
Depreciation & Amortization	10.83	9.84	6.08	6.57	7.59	8.01	Upgrade
EBIT	-162.17	-112.54	-162.96	-157.3	-129.93	-136.92	Upgrade
EBIT Margin	-883.39%	-186.68%	-600.26%	-2558.12%	-3282.72%	-12203.48%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).